BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30431073)

  • 1. miR‑494.3p expression in synovial sarcoma: Role of CXCR4 as a potential target gene.
    Pazzaglia L; Pollino S; Vitale M; Bientinesi E; Benini S; Ferrari C; Palmerini E; Gambarotti M; Picci P; Benassi MS
    Int J Oncol; 2019 Jan; 54(1):361-369. PubMed ID: 30431073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic and predictive role of CXCR4, IGF-1R and Ezrin expression in localized synovial sarcoma: is chemotaxis important to tumor response?
    Palmerini E; Benassi MS; Quattrini I; Pazzaglia L; Donati D; Benini S; Gamberi G; Gambarotti M; Picci P; Ferrari S
    Orphanet J Rare Dis; 2015 Jan; 10():6. PubMed ID: 25613038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer.
    Shen PF; Chen XQ; Liao YC; Chen N; Zhou Q; Wei Q; Li X; Wang J; Zeng H
    Prostate; 2014 May; 74(7):756-67. PubMed ID: 24644030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-494 acts as a tumor suppressor in pancreatic cancer, inhibiting epithelial-mesenchymal transition, migration and invasion by binding to SDC1.
    Yang Y; Tao X; Li CB; Wang CM
    Int J Oncol; 2018 Sep; 53(3):1204-1214. PubMed ID: 29956739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL12/CXCR4 promotes inflammation-driven colorectal cancer progression through activation of RhoA signaling by sponging miR-133a-3p.
    Yu X; Wang D; Wang X; Sun S; Zhang Y; Wang S; Miao R; Xu X; Qu X
    J Exp Clin Cancer Res; 2019 Jan; 38(1):32. PubMed ID: 30678736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA 338-3p exhibits tumor suppressor role and its down-regulation is associated with adverse clinical outcome in prostate cancer patients.
    Bakkar A; Alshalalfa M; Petersen LF; Abou-Ouf H; Al-Mami A; Hegazy SA; Feng F; Alhajj R; Bijian K; Alaoui-Jamali MA; Bismar TA
    Mol Biol Rep; 2016 Apr; 43(4):229-40. PubMed ID: 26907180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-133b, a muscle-specific microRNA, is a novel prognostic marker that participates in the progression of human colorectal cancer via regulation of CXCR4 expression.
    Duan FT; Qian F; Fang K; Lin KY; Wang WT; Chen YQ
    Mol Cancer; 2013 Dec; 12():164. PubMed ID: 24330809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plumbagin inhibits invasion and migration of breast and gastric cancer cells by downregulating the expression of chemokine receptor CXCR4.
    Manu KA; Shanmugam MK; Rajendran P; Li F; Ramachandran L; Hay HS; Kannaiyan R; Swamy SN; Vali S; Kapoor S; Ramesh B; Bist P; Koay ES; Lim LH; Ahn KS; Kumar AP; Sethi G
    Mol Cancer; 2011 Sep; 10():107. PubMed ID: 21880153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating MicroRNA-92b-3p as a Novel Biomarker for Monitoring of Synovial Sarcoma.
    Uotani K; Fujiwara T; Yoshida A; Iwata S; Morita T; Kiyono M; Yokoo S; Kunisada T; Takeda K; Hasei J; Numoto K; Nezu Y; Yonemoto T; Ishii T; Kawai A; Ochiya T; Ozaki T
    Sci Rep; 2017 Nov; 7(1):14634. PubMed ID: 29116117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer metastasis: demonstration that FOXP3 regulates CXCR4 expression and the response to CXCL12.
    Douglass S; Meeson AP; Overbeck-Zubrzycka D; Brain JG; Bennett MR; Lamb CA; Lennard TW; Browell D; Ali S; Kirby JA
    J Pathol; 2014 Sep; 234(1):74-85. PubMed ID: 24870556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of visfatin in promoting proliferation and invasion of colorectal cancer cells by downregulating SDF-1/CXCR4-mediated miR-140-3p expression.
    Zhao Q; Li JY; Zhang J; Long YX; Li YJ; Guo XD; Wei MN; Liu WJ
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5367-5377. PubMed ID: 32495871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-142-3p as tumor suppressor miRNA in the regulation of tumorigenicity, invasion and migration of human breast cancer by targeting Bach-1 expression.
    Mansoori B; Mohammadi A; Ghasabi M; Shirjang S; Dehghan R; Montazeri V; Holmskov U; Kazemi T; Duijf P; Gjerstorff M; Baradaran B
    J Cell Physiol; 2019 Jun; 234(6):9816-9825. PubMed ID: 30480817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of chemokine (CXC motif) ligand 12/chemokine (CXC motif) receptor 4 axis (CXCL12/CXCR4)-mediated cell migration by targeting mammalian target of rapamycin (mTOR) pathway in human gastric carcinoma cells.
    Chen G; Chen SM; Wang X; Ding XF; Ding J; Meng LH
    J Biol Chem; 2012 Apr; 287(15):12132-41. PubMed ID: 22337890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of CXCL12-CXCR4 axis in ovarian cancer metastasis and CXCL12-CXCR4 blockade with AMD3100 suppresses tumor cell migration and invasion in vitro.
    Liu Y; Ren CC; Yang L; Xu YM; Chen YN
    J Cell Physiol; 2019 Apr; 234(4):3897-3909. PubMed ID: 30191987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.
    Arya M; Patel HR; McGurk C; Tatoud R; Klocker H; Masters J; Williamson M
    J Exp Ther Oncol; 2004 Dec; 4(4):291-303. PubMed ID: 15844659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL14, CXCR7 expression and CXCR4 splice variant ratio associate with survival and metastases in Ewing sarcoma patients.
    Sand LG; Scotlandi K; Berghuis D; Snaar-Jagalska BE; Picci P; Schmidt T; Szuhai K; Hogendoorn PC
    Eur J Cancer; 2015 Nov; 51(17):2624-33. PubMed ID: 26428435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosome-encapsulated miRNAs contribute to CXCL12/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophages.
    Wang D; Wang X; Si M; Yang J; Sun S; Wu H; Cui S; Qu X; Yu X
    Cancer Lett; 2020 Apr; 474():36-52. PubMed ID: 31931030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of CXCL12/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway.
    Zhao S; Wang J; Qin C
    J Exp Clin Cancer Res; 2014 Dec; 33(1):103. PubMed ID: 25471741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-9 inhibits growth and invasion of head and neck cancer cells and is a predictive biomarker of response to plerixafor, an inhibitor of its target CXCR4.
    Hersi HM; Raulf N; Gaken J; Folarin N; Tavassoli M
    Mol Oncol; 2018 Dec; 12(12):2023-2041. PubMed ID: 29959873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
    Qiao N; Wang L; Wang T; Li H
    Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.